Funder: Jeffrey Modell Foundation

Due Dates (Anticipated): March 2026 (Letter of Intent) | July 2026 (Full application, invited investigators)

Funding Amounts: Up to $250,000 total over two years (max $125,000/year); direct costs only, no overhead

Summary: Supports innovative translational research in Primary Immunodeficiency (PI), advancing clinical applications and understanding of immune mechanisms to improve patient outcomes.

Key Information: Forecasted dates—confirm deadlines on program page; only one active grant per investigator at a time.